Capricor Therapeutics Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CAPR Nasdaq 2836 http://capricor.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Capricor Therapeutics Inc

Capricor to Participate in BIO Digital International Convention - Jun 4th, 2020 1:15 pm
Here is What Hedge Funds Think About Capricor Therapeutics, Inc. (CAPR) - May 29th, 2020 5:08 pm
Capricor to Participate in Maxim Group's COVID-19 Virtual Conference Series on May 27, 2020 - May 26th, 2020 1:25 pm
Capricor Therapeutics (CAPR) Reports Q1 Loss, Lags Revenue Estimates - May 14th, 2020 9:35 pm
Capricor Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update - May 14th, 2020 8:01 pm
Capricor Therapeutics to Present First Quarter 2020 Financial Results and Recent Corporate Update on May 14 - May 13th, 2020 8:30 pm
Capricor (CAPR) Shares Could Hit $10, Says Analyst - May 6th, 2020 10:44 pm
Capricor Therapeutics Shares Soar 250% On Successful COVID-19 Treatment News - Apr 30th, 2020 4:23 am
New Capricor Data Reports 100 Percent Survival in Critical COVID-19 Patients Treated with CAP-1002 - Apr 29th, 2020 1:15 pm
Did You Manage To Avoid Capricor Therapeutics' (NASDAQ:CAPR) 97% Share Price Wipe Out? - Apr 24th, 2020 11:31 am
Capricor Therapeutics to Host Key Opinion Leader Call on Cardiac Complications of Duchenne Muscular Dystrophy - Apr 13th, 2020 1:00 pm
This Penny Stock Joins the Fight Against Coronavirus; Analyst Sees Triple-Digit Upside - Apr 6th, 2020 8:02 pm
Capricor Initiates Compassionate Use Program for Severe COVID-19 Patients using CAP-1002, its Novel Cell Therapy - Apr 3rd, 2020 12:00 pm
Capricor Therapeutics to Host a Key Opinion Leader Call On Why Exosomes are Uniquely Suited for Vaccine Development - Mar 24th, 2020 12:00 pm
Capricor Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update - Mar 18th, 2020 8:01 pm
Capricor Therapeutics, Inc. to Host Earnings Call - Mar 18th, 2020 6:30 pm
Capricor Therapeutics Announces Strategic Plan for Exosome Platform Technology Products Expansion - Mar 17th, 2020 12:00 pm
Capricor Therapeutics to Present Fourth Quarter and Full Year 2019 Financial Results and Recent Corporate Update on March 18 - Mar 11th, 2020 8:30 pm
Does Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO Pay Reflect Performance? - Mar 10th, 2020 11:01 am